Document is current
Any future updates will be listed below
-
Authors
Bizzaro, Francesca
Fuso Nerini, Ilaria
Taylor, Molly A.
Anastasia, Alessia
Russo, Massimo
Damia, Giovanna
Guffanti, Federica
Guana, Francesca
Ostano, Paola
Minoli, Lucia
Hattersley, Maureen M.
Arnold, Stephanie
Ramos-Montoya, Antonio
Williamson, Stuart C.
Galbiati, Alessandro
Urosevic, Jelena
Leo, Elisabetta
Cavallaro, Ugo
Ghilardi, Carmen
Barry, Simon T.
Bani, Maria Rosa https://orcid.org/0000-0001-8178-1432
Giavazzi, Raffaella
-
Funding
Funding for this research was provided by:
associazione italiana per la ricerca sul cancro (IG23520, IG19797, IG21320)
- License Information
-
More Information
Article History
Received: 4 August 2021
Accepted: 18 October 2021
First Online: 6 November 2021
Declarations
:
: Animal studies were approved by the Mario Negri Institute Animal Care and Use Committee (IACUC) and authorised by the Italian Ministry of Health, Directorate-General for Animal Health and Veterinary Medicines. Experimental procedures involving mice and their care were conducted in conformity with institutional guidelines (Mario Negri Institutional Regulations and Policies - Quality Management System Certificate UNI EN ISO 9001:2008 Reg, No. 6121), in compliance with national and international laws and policies regulating animal testing (Italian D. Lgs 26/2014; EEC Council Directive 2010/63/UE).
: Not applicable.
: MAT, MMH, SA, AR, SCW, AG, JU, EL, STB are AstraZeneca employees and shareholders. All other authors declare no competing interests.
